Kanavaros P, Lavergne A, Galian A, Boivin P, Fourmestreaux A R, Priollet B C, Flandrin G, Hautefeuille P
Department of Pathology, Lariboisière Hospital, Paris, France.
Am J Surg Pathol. 1988 Aug;12(8):641-7.
We report an aggressive primary T-immunoblastic lymphoma of the small intestine without blood involvement or associated celiac disease. Grossly, the tumor was composed of multiple disseminated ulcerated, infiltrating, or protuberant nodular lesions. Immunologic investigation showed that lymphoma cells were of peripheral (post-thymic) T-cell origin and expressed the phenotype associated with cytotoxic-suppressor subset (Leu4/CD3+, Leu9/CD7+, Leu2/CD8+, Leu11/CD16+, Leu 7/NKcells+, FcIgG+, HLA-DR+, anti-Tac/CD25+, Ki-1/CD30-, Leu1/CD5-, Leu5/CD2-, Leu3/CD4-). A particular morphologic feature of this case is the presence of numerous azurophilic granules within the lymphoma cells, identified as lysosomes by cytochemical and ultrastructural studies. In view of recent immunologic evidence that normal cytotoxic/suppressor T-cells selectively reside within the epithelium of the normal bowel and some of them contain azurophilic granules, it could be suggested that our patient's lymphoma represents a malignant counterpart of these lymphocytes. Furthermore, the aggressive character of this T malignant lymphoma (T-ML) could be related to the expression of T-cell activation markers HLA-DR and Tac/CD25 and the proliferation-associated antigen Ki-67 on a high proportion of tumor cells.
我们报告一例原发性小肠侵袭性T免疫母细胞淋巴瘤,无血液受累或相关乳糜泻。大体上,肿瘤由多个散在的溃疡、浸润或突出的结节性病变组成。免疫研究显示淋巴瘤细胞起源于外周(胸腺后)T细胞,并表达与细胞毒性抑制亚群相关的表型(Leu4/CD3 +、Leu9/CD7 +、Leu2/CD8 +、Leu11/CD16 +、Leu 7/NK细胞 +、FcIgG +、HLA - DR +、抗Tac/CD25 +、Ki - 1/CD30 -、Leu1/CD5 -、Leu5/CD2 -、Leu3/CD4 -)。该病例的一个特殊形态学特征是淋巴瘤细胞内存在大量嗜天青颗粒,通过细胞化学和超微结构研究鉴定为溶酶体。鉴于最近的免疫学证据表明正常细胞毒性/抑制性T细胞选择性地存在于正常肠道上皮内,其中一些含有嗜天青颗粒,提示我们患者的淋巴瘤可能是这些淋巴细胞的恶性对应物。此外,这种T恶性淋巴瘤(T - ML)的侵袭性可能与高比例肿瘤细胞上T细胞活化标志物HLA - DR和Tac/CD25以及增殖相关抗原Ki - 67的表达有关。